RS261332 Unknown gene

Other Chr 15:58435126
Upload your DNA to see your genotype for this variant.
What This Variant Does
"rs261332 increases susceptibility to Elevated HDL-Cholesterol for carriers of the A allele A allele ..."
GWAS Studies (20)
Trait Risk Allele OR / Beta P-value Study
Low-density lipoprotein levels (MTAG) A β: 0.064 2E-310 PubMed
Cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23581) A β: 0.095 1E-58 PubMed
Age-related disease endophenotypes 4E-42 PubMed
Age-related diseases, mortality and associated endophenotypes 2E-35 PubMed
High density lipoprotein cholesterol levels A OR: 1.58 3E-25 PubMed
Total lipids in small HDL G β: 0.02 2E-22 PubMed
Postprandial triglycerides levels in IDL G OR: 0.26 2E-22 PubMed
High density lipoprotein cholesterol levels T OR: 2.59 9E-21 PubMed
Cholesterol levels in medium VLDL A β: 0.042 1E-16 PubMed
Cholesteryl ester levels in medium VLDL A β: 0.041 2E-16 PubMed
Triglyceride levels (MTAG) A β: 0.025 4E-16 PubMed
Hematocrit A β: 0.014 1E-15 PubMed
Fasting triglycerides levels in small LDL G OR: 0.19 1E-13 PubMed
Free cholesterol levels in large LDL A β: 0.037 2E-13 PubMed
Phosphatidylethanolamine(38:5)_[M-H]1- levels G β: 0.08 7E-13 PubMed
Phosphatidylcholine(35:4)_[M+H]1+/Phosphatidylethanolamine(38:4)_[M+H]1+/Phosphatidate(40:5)_[M+NH4]1+ levels G β: 0.057 7E-13 PubMed
Phosphatidylethanolamine(40:7)_[M-H]1- levels T β: 0.085 7E-13 PubMed
Phosphatidylcholine(37:6)_[M+H]1+/Phosphatidylethanolamine(40:6)_[M+H]1+/Phosphatidate(42:7)_[M+NH4]1+ levels G OR: 0.19 7E-13 PubMed
Phosphatidylcholine(33:3)_[M+H]1+/Phosphatidylethanolamine(36:3)_[M+H]1+/Phosphatidate(38:4)_[M+NH4]1+ levels C OR: 0.19 7E-13 PubMed
Phosphatidylcholine(33:2)_[M+H]1+/Phosphatidylethanolamine(36:2)_[M+H]1+/Phosphatidate(38:3)_[M+NH4]1+ levels A OR: 0.19 7E-13 PubMed
Ask Dr. Hemsworth about this variant